Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection

Pediatric Transplantation

Volumn 13, Issue 4, 2009, Pages 475-481

  Krischock, L ^a   Gullett, A ^a   Bockenhauer, D ^a   Rees, L ^a   Trompeter, R S ^a   Marks, S D ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Great Ormond Street Hospital for Sick Children NHS Trust ^*  (United Kingdom)

Author keywords

Cyclosporine; Kidney transplantation; Mycophenoloic acid; Pediatrics; Rejection; Tacrolimus

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOWER RESPIRATORY TRACT INFECTION; LYMPHOPROLIFERATIVE DISEASE; MALE; NAUSEA; NEUTROPENIA; PANCYTOPENIA; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VERRUCA VULGARIS; VIREMIA; VIRUS INFECTION; WEIGHT REDUCTION;

ADOLESCENT; BLOOD PRESSURE; CALCINEURIN; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES;

EID: 65549170005     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01031.x     Document Type: Article

References (18)

1. Ettenger R, Sarwal MM. Mycophenolate mofetil in pediatric renal transplantation. Transplantation 2005 : 80 : S201 S210. (Pubitemid 41552907)
2. Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation 2005 : 80 : S211 S220. (Pubitemid 41552908)
3. Otukesh H, Sharifian M, Basiri A, et al. Mycophenolate mofetil in pediatric renal transplantation. Transplant Proc 2005 : 37 : 3012 3015. (Pubitemid 41435602)
4. Ferraris JR, Ghezzi LFR, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET. Improved long-term allograft function in paediatric renal transplantation with mycophenolate mofetil. Pediatr Transplant 2005 : 9 : 178 182. (Pubitemid 40476844)
5. Ciancio G, Miller J, Gonwa TA. Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation 2005 : 80 : S191 S200. (Pubitemid 41552906)
6. Benz K, Plank C, Griebel M, Montoya M, Dotsch J, Klare B. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in paediatric renal transplant recipients: A retrospective analysis. Pediatr Transplant 2006 : 10 : 331 336.
7. Henne T, Latta K, Strehlau J, Pape L, Ehrich JHH, Offner G. Mycophenolate-mofetil induced reversal of glomerular filtration loss in children with chronic allograft nephropathy. Transplantation 2003 : 76 : 1326 1330. (Pubitemid 37430719)
8. Jungraithmayr TC, Wiesmayr S, Staskewitz A, et al. Five-year outcome in pediatric patients with mycophenolate-mofetil based renal transplantation. Transplantation 2007 : 83 : 900 905. (Pubitemid 46682730)
9. Fujihara CK, Costa DMA, Zatz R, Nouronha IL. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 1998 : 54 : 1510 1519. (Pubitemid 28502893)
10. Kerecuk L, Taylor J, Clark G. Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients. Pediatr Nephrol 2005 : 20 : 1630 1635. (Pubitemid 41554478)
11. Kausman JY, Patel B, Marks SD. Standard dosing of tacrolimus leads to overexposure in paediatric renal transplantation recipients. Pediatr Transplant 2008 : 12 : 329 335.
12. Solez K, Colvin RB, Racusen LC, et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transplant 2007 : 7 : 518 526. (Pubitemid 46376465)
13. Merville P, Berge F, Derminiere C, et al. Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil. Am J Transplant 2004 : 4 : 1769 1775. (Pubitemid 39434436)
14. Afzali B, Shah S, Chowdhury P, O'sullivan H, Taylor J, Goldsmith D. Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy. Transplantation 2005 : 79 : 304 309. (Pubitemid 40299536)
15. Dudley C, Pohanka E, Riad H, et al. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: The "creeping creatinine" study 1. Transplantation 2005 : 79 : 466 475. (Pubitemid 40280180)
16. Gonzalez Molina M, Seron D, Garcia Del Moral R, et al. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Group of Chronic Allograft Nephropathy. Transplantation 2004 : 77 : 215 219. (Pubitemid 38155749)
17. Gonzalez Molina M, Seron D, Garcia Del Moral R, et al. Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: A Spanish multicenter study. Transplant Proc 2002 : 34 : 335 337. (Pubitemid 34311697)
18. Weir MR, Blahutt S, Drachenburg C, et al. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function. Am J Nephrol 2004 : 24 : 379 386. (Pubitemid 39279378)